301258 Product Name: Combinatie van trifluridine en tipiracil of een zout daarvan met bevacizumab
Filing date | Document type | Document Description | Number of pages | File Type | ||
---|---|---|---|---|---|---|
14/03/2025 | Appeal | Annex | 7 | /3/5/7/5/6/0800965753/docs/301258_17_appeal20250318121702026.pdf | ||
14/03/2025 | Appeal | Annex | 21 | /3/5/7/5/6/0800965753/docs/301258_18_appeal20250318121702051.pdf | ||
14/03/2025 | Appeal | Annex | 28 | /3/5/7/5/6/0800965753/docs/301258_19_appeal20250318121702060.pdf | ||
12/03/2025 | Appeal | Accompanying letter appeal procedure | 7 | /3/5/7/5/6/0800965753/docs/301258_14_appeal20250313105713595.pdf | ||
12/03/2025 | Appeal | Annex | 21 | /3/5/7/5/6/0800965753/docs/301258_15_appeal20250313105752291.pdf | ||
12/03/2025 | Appeal | Annex | 28 | /3/5/7/5/6/0800965753/docs/301258_16_appeal20250313105942460.pdf | ||
10/10/2024 | Outgoing Correspondence | Confirmation receipt appeal | 1 | /3/5/7/5/6/0800965753/docs/301258_10_626318l072.pdf | ||
10/10/2024 | Appeal | Request appeal | 7 | /3/5/7/5/6/0800965753/docs/301258_11_appeal20241010030553104.pdf | ||
09/10/2024 | Appeal | Request appeal | 2 | /3/5/7/5/6/0800965753/docs/301258_9_appeal20241010011629492.pdf | ||
29/08/2024 | Outgoing Correspondence | Decision refusal | 5 | /3/5/7/5/6/0800965753/docs/301258_0_619735l527a.pdf | ||
28/06/2024 | SPC Documents | Annex SPC | 21 | /3/5/7/5/6/0800965753/docs/301258_12_supplprotectioncertificate20240628043445655.pdf | ||
28/06/2024 | Incoming Correspondence Electronic | Incoming Correspondence Paper | 5 | /3/5/7/5/6/0800965753/docs/301258_13_incomingcorrespondenceelectronic20240628043347124.pdf | ||
31/01/2024 | Outgoing Correspondence | Letter to applicant | 3 | /3/5/7/5/6/0800965753/docs/301258_1_588358l173.pdf | ||
25/01/2024 | Outgoing Correspondence | Confirmation receipt request | 2 | /3/5/7/5/6/0800965753/docs/301258_2_588072l174.pdf | ||
24/01/2024 | Application Form | First filed application form | 4 | /3/5/7/5/6/0800965753/docs/301258_3_applicationform20240124035912803.pdf | ||
24/01/2024 | SPC Documents | Marketing Authorization SPC | 3 | /3/5/7/5/6/0800965753/docs/301258_4_supplprotectioncertificate20240124040502196.pdf | ||
24/01/2024 | SPC Documents | Annex SPC | 1 | /3/5/7/5/6/0800965753/docs/301258_5_supplprotectioncertificate20240124040432071.pdf | ||
24/01/2024 | SPC Documents | Summary of the characteristics of the product | 28 | /3/5/7/5/6/0800965753/docs/301258_6_supplprotectioncertificate20240124040412687.pdf | ||
24/01/2024 | SPC Documents | Annex SPC | 2 | /3/5/7/5/6/0800965753/docs/301258_7_supplprotectioncertificate20240124040109665.pdf | ||
24/01/2024 | SPC Documents | Annex SPC | 2 | /3/5/7/5/6/0800965753/docs/301258_8_supplprotectioncertificate20240124043242666.pdf |